Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ly4100511

Contact Research Centre

Psoriasis

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bi 3032950

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Gs-1427

Contact Research Centre

Crohn's disease

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Hidradenitis

Not recruiting

Registered drug

Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Cough

Not recruiting

Investigational

Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Camlipixant

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Acute haemorrhagic ulcerative colitis

Not recruiting

Registered drugNo placebo

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Omalizumab

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 14

339 trials match your criteria

Psoriasis

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Psoriasis

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Psoriasis

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Colitis ulcerative

Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

Colitis ulcerative

Study on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis

Crohn's disease

Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease

Hidradenitis

Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

Cough

Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Neurodermatitis

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Acute haemorrhagic ulcerative colitis

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Chronic spontaneous urticaria

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.